Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 6
1984 3
1985 2
1987 6
1988 3
1989 8
1990 8
1991 6
1992 9
1993 4
1994 2
1995 7
1996 1
1997 1
1998 1
1999 2
2000 1
2003 1
2004 4
2005 3
2006 5
2007 5
2008 4
2009 2
2015 5
2017 4
2018 4
2020 3
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Biodegradable poly(DL-lactide-co-glycolide) microspheres.
Eldridge JH, Staas JK, Tice TR, Gilley RM. Eldridge JH, et al. Res Immunol. 1992 Jun;143(5):557-63; discussion 581. doi: 10.1016/0923-2494(92)80069-w. Res Immunol. 1992. PMID: 1439138 Review. No abstract available.
Liposomes as oral adjuvants.
Michalek SM, Childers NK, Katz J, Denys FR, Berry AK, Eldridge JH, McGhee JR, Curtiss R 3rd. Michalek SM, et al. Among authors: eldridge jh. Curr Top Microbiol Immunol. 1989;146:51-8. doi: 10.1007/978-3-642-74529-4_5. Curr Top Microbiol Immunol. 1989. PMID: 2659275 Review.
Immune correlates of postexposure vaccine protection against Marburg virus.
Woolsey C, Jankeel A, Matassov D, Geisbert JB, Agans KN, Borisevich V, Cross RW, Deer DJ, Fenton KA, Latham TE, Gerardi CS, Mire CE, Eldridge JH, Messaoudi I, Geisbert TW. Woolsey C, et al. Among authors: eldridge jh. Sci Rep. 2020 Feb 20;10(1):3071. doi: 10.1038/s41598-020-59976-3. Sci Rep. 2020. PMID: 32080323 Free PMC article.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
Eldridge JH, Egan MA, Matassov D, Hamm S, Hermida L, Chen T, Tremblay M, Sciotto-Brown S, Xu R, Dimitrov A, Smith ER, Gurwith M, Chen RT; Benefit-Risk Assessment of VAccines by TechnolOgy Working Group BRAVATO, ex-V3SWG). Eldridge JH, et al. Vaccine. 2021 Sep 7;39(38):5436-5441. doi: 10.1016/j.vaccine.2021.07.030. Epub 2021 Aug 7. Vaccine. 2021. PMID: 34373117 Free article. Review.
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.
Cross RW, Xu R, Matassov D, Hamm S, Latham TE, Gerardi CS, Nowak RM, Geisbert JB, Ota-Setlik A, Agans KN, Luckay A, Witko SE, Soukieh L, Deer DJ, Mire CE, Feldmann H, Happi C, Fenton KA, Eldridge JH, Geisbert TW. Cross RW, et al. Among authors: eldridge jh. J Clin Invest. 2020 Jan 2;130(1):539-551. doi: 10.1172/JCI131958. J Clin Invest. 2020. PMID: 31820871 Free PMC article.
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
Suksanpaisan L, Xu R, Tesfay MZ, Bomidi C, Hamm S, Vandergaast R, Jenks N, Steele MB, Ota-Setlik A, Akhtar H, Luckay A, Nowak R, Peng KW, Eldridge JH, Clarke DK, Russell SJ, Diaz RM. Suksanpaisan L, et al. Among authors: eldridge jh. Mol Ther Oncolytics. 2018 Jul 5;10:1-13. doi: 10.1016/j.omto.2018.05.001. eCollection 2018 Sep 28. Mol Ther Oncolytics. 2018. PMID: 29998190 Free PMC article.
109 results